Is EXOZ research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EXOZ. It does not provide personalized investment advice.

EXOZ (eXoZymes Inc. Common Stock) Stock Analysis - Financials

eXoZymes Inc. Common Stock (EXOZ) is a publicly traded Healthcare sector company. As of October 16, 2026, EXOZ trades at $4.31 with a market cap of $42.80M and a P/E ratio of -5.10. EXOZ moved +23.50% today. Year to date, EXOZ is -65.19%; over the trailing twelve months it is -69.92%. Its 52-week range spans $3.71 to $20.87. Rallies surfaces EXOZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are EXOZ's key financials?

EXOZ financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EXOZ recently traded at $4.31. Market cap is $42.80M. P/E ratio is -5.10. Revenue is $0.

EXOZ Key Metrics

Key financial metrics for EXOZ
Metric	Value
Price	$4.31
Market Cap	$42.80M
P/E Ratio	-5.10
EPS	$-1.09
Dividend Yield	0.00%
52-Week High	$20.87
52-Week Low	$3.71
Volume	27.06K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-9.16M
Gross Margin	0.00%

EXOZ Analyst Consensus

EXOZ analyst coverage data. Average price target: $0.00.

Common questions about EXOZ

What are EXOZ's key financials?: EXOZ financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EXOZ recently traded at $4.31. Market cap is $42.80M. P/E ratio is -5.10. Revenue is $0.
Is EXOZ research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EXOZ. It does not provide personalized investment advice.